Primary care providers (PCPs) stand on the front lines of diagnosing clinically significant valvular heart disease (VHD) ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
June 29, 2026 — A new international expert consensus document refines and updates how heart failure is identified and ...
June 29, 2026 — Konica Minolta, Inc. has announced that a research group has developed a simple and rapid technique for ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
June 18, 2026 — Nyra Medical has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for ...
A physical exam and echocardiogram have been the traditional tools for diagnosing aortic stenosis. Yet many patients ...
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
June 8, 2026 – Embolization, Inc. will present its novel embolization coil, using proprietary shape-memory biocompatible ...
June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 28, 2026 — Coredio has announced that the U.S. Food and Drug Administration (FDA) has granted its Cardiac ...
May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone ...
July 01, 2026